Rascol O - Search Results

1

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.

Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups. Rascol O, et al. Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8. Parkinsonism Relat Disord. 2022. PMID: 35227940 Free article. Clinical Trial.

2

Limitations of current Parkinson's disease therapy.

Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Rascol O, et al. Ann Neurol. 2003;53 Suppl 3:S3-12; discussion S12-5. doi: 10.1002/ana.10513. Ann Neurol. 2003. PMID: 12666094 Review.

3

Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.

Ziegler M, Castro-Caldas A, Del Signore S, Rascol O. Ziegler M, et al. Among authors: rascol o. Mov Disord. 2003 Apr;18(4):418-25. doi: 10.1002/mds.10359. Mov Disord. 2003. PMID: 12671949 Clinical Trial.

4

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Among authors: rascol o. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

5

Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.

Zijlmans JC, Debilly B, Rascol O, Lees AJ, Durif F. Zijlmans JC, et al. Among authors: rascol o. Mov Disord. 2004 Sep;19(9):1006-1011. doi: 10.1002/mds.20188. Mov Disord. 2004. PMID: 15372589 Clinical Trial.

6

Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease.

Reichmann H, Bilsing A, Ehret R, Greulich W, Schulz JB, Schwartz A, Rascol O. Reichmann H, et al. Among authors: rascol o. J Neurol. 2006 Aug;253 Suppl 4:IV36-8. doi: 10.1007/s00415-006-4009-z. J Neurol. 2006. PMID: 16944356

7

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.

Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H. Goetz CG, et al. Among authors: rascol o. Mov Disord. 2007 Jan 15;22(2):179-86. doi: 10.1002/mds.21226. Mov Disord. 2007. PMID: 17094088 Clinical Trial.

8

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.

Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE. Hauser RA, et al. Among authors: rascol o. Mov Disord. 2007 Dec;22(16):2409-17. doi: 10.1002/mds.21743. Mov Disord. 2007. PMID: 17894339 Clinical Trial.

9

Placebo influences on dyskinesia in Parkinson's disease.

Goetz CG, Laska E, Hicking C, Damier P, Müller T, Nutt J, Warren Olanow C, Rascol O, Russ H. Goetz CG, et al. Among authors: rascol o. Mov Disord. 2008 Apr 15;23(5):700-7. doi: 10.1002/mds.21897. Mov Disord. 2008. PMID: 18175337 Free PMC article.

10

Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.

Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, Yelnik J, Samson Y, Rascol O, Agid Y, Damier P. Payoux P, et al. Among authors: rascol o. J Cereb Blood Flow Metab. 2009 Feb;29(2):235-43. doi: 10.1038/jcbfm.2008.107. Epub 2008 Sep 10. J Cereb Blood Flow Metab. 2009. PMID: 18781162 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page